109 related articles for article (PubMed ID: 7981068)
21. Compliance with follow-up of patients treated for non-seminomatous testicular cancer.
Young BJ; Bultz BD; Russell JA; Trew MS
Br J Cancer; 1991 Sep; 64(3):606-8. PubMed ID: 1911207
[TBL] [Abstract][Full Text] [Related]
22. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance.
Subramanian VS; Gilligan T; Klein EA
Nat Clin Pract Urol; 2008 Apr; 5(4):220-3. PubMed ID: 18268549
[TBL] [Abstract][Full Text] [Related]
23. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
[TBL] [Abstract][Full Text] [Related]
24. Surveillance-only policy in clinical stage-I non-seminomatous germ-cell tumors of the testis.
Tekgül S; Ozen H; Ozgü I; Sahin A; Ergen A; Remzi D
Bull Cancer; 1995 Jan; 82(2):162-6. PubMed ID: 10846534
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
26. Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary.
Pierorazio PM; Albers P; Black PC; Tandstad T; Heidenreich A; Nicolai N; Nichols C
Eur Urol; 2018 Jun; 73(6):899-907. PubMed ID: 29338978
[TBL] [Abstract][Full Text] [Related]
27. Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance.
Thompson PI; Nixon J; Harvey VJ
J Clin Oncol; 1988 Oct; 6(10):1597-603. PubMed ID: 2459319
[TBL] [Abstract][Full Text] [Related]
28. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L; Gomez F; Bak M; Bodrogi I
J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant chemotherapy for stage I non-seminomatous testicular cancer.
Abratt RP; Pontin AR; Barnes RD; Reddi BV
S Afr Med J; 1994 Sep; 84(9):605-7. PubMed ID: 7530863
[TBL] [Abstract][Full Text] [Related]
30. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
31. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse.
Rabbani F; Sheinfeld J; Farivar-Mohseni H; Leon A; Rentzepis MJ; Reuter VE; Herr HW; McCaffrey JA; Motzer RJ; Bajorin DF; Bosl GJ
J Clin Oncol; 2001 Apr; 19(7):2020-5. PubMed ID: 11283135
[TBL] [Abstract][Full Text] [Related]
32. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
33. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic retroperitoneal lymphadenectomy for stage I non-seminomatous testicular tumors.
Custureri F; Urciuoli P; Iavarone C; D'Orazi V; Gabatel R; Ghinassi S; Patrizi G; Palazzini G; Di Matteo FM; Peparini N
Hepatogastroenterology; 2005; 52(66):1677-80. PubMed ID: 16334755
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of patients with stage I non-seminomatous testicular tumors with general orchiectomy].
Hornák M; Ondrus D
Z Urol Nephrol; 1988 Sep; 81(9):541-5. PubMed ID: 2853503
[TBL] [Abstract][Full Text] [Related]
36. Clinical analysis of management of pediatric testicular germ cell tumors.
Ye YL; Sun XZ; Zheng FF; Bian J; Huang YP; Zhang XQ; Li ZX; Nie Y; Qin ZK; Dai YP
Urology; 2012 Apr; 79(4):892-7. PubMed ID: 22305424
[TBL] [Abstract][Full Text] [Related]
37. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
38. Late recurrence with malignant degeneration of testicular teratoma. Case report.
Bulbul MA; Farhat W; Shabb NS; Salem Z
J Med Liban; 1998; 46(2):103-5. PubMed ID: 10095838
[TBL] [Abstract][Full Text] [Related]
39. An unusual late relapse in pathologic stage I non-seminomatous germ cell tumor: case report and review of the literature.
Bilgrami S; Chen L; Shafi N; Synnott V; Greenberg B
Urol Int; 1994; 53(3):176-8. PubMed ID: 7544042
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy.
Hoskin P; Dilly S; Easton D; Horwich A; Hendry W; Peckham MJ
J Clin Oncol; 1986 Jul; 4(7):1031-6. PubMed ID: 2425060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
